Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study

Authors:

Abstract
No abstract available
Funding Information
  • Genentech

This publication has 33 references indexed in Scilit: